Peptide RX

back to claim graph

proof receipt / fold

GCGR WT

Structure prediction with public confidence context.

grade B status complete receipt ac92dae5c8bb proof 67%

what this node claims

GCGR WT

Structure prediction with public confidence context.

Open source surface

vertical proof spine

  1. 01 GCGR WT fold / grade B / 66% 2 debt
  2. 02 AlphaFold metrics / GCGR alphafold metric / grade B / 74% 1 debt
  3. 03 Initial digest — GCGR finding / grade C / 47% 1 debt
  4. 04 fold.complete timeline event / grade C / 55%
  5. 05 GCGR target / grade B / 70% 1 debt

evidence / risk instrument

50%
thin proof
structure evidence gates risk export lineage 50
visible debt pressure 47%
82%structurestrong
pLDDT 81.9
55%evidencethin
grade C
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
67%lineageusable
incomplete spine

proof completeness

67% missing candidate, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

confidence band
confident
confidence pct
81.9
coverage available
false
gene
GCGR
has structure
true
pae available
false
plddt avg
81.9
sequence length
0
variant
WT

AlphaFold metrics visual

Confident backbone model

81.9

477 residues / min 31.25 / max 98.06 / source alphafold db

PAE matrix for linked target
Very high 49.5% 236 residues / >=90
Confident 32.1% 153 residues / 70-89
Low 7.8% 37 residues / 50-69
Very low 10.7% 51 residues / <50

usable fold context with explicit model-confidence limits

Near-complete coverage / observed 477 of 477 residues.

  • residues 432-477 / mean 45.24
  • residues 1-27 / mean 47.56
  • residues 256-261 / mean 67.28
  • residues 369-373 / mean 65.1
proof debt register

Visible limits, not hidden cleanup.

47%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

low computational-only status add independent evidence, challenge result, or witness review before strengthening
medium no candidate yet leave visible until a stronger public receipt resolves it
medium missing PAE/context where AlphaFold DB is not linked attach pLDDT series, PAE matrix, or coverage evidence
high low evidence grade attach graded finding with source-linked evidence
medium missing functional-site annotations link target annotation, GO term, or binding-site context

weakness and challenge edges

What would stop this from becoming stronger.

debt severity export claim strength next proof needed
computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it
missing PAE/context where AlphaFold DB is not linked medium visible weakens attach pLDDT series, PAE matrix, or coverage evidence
low evidence grade high blocks weakens attach graded finding with source-linked evidence
missing functional-site annotations medium visible weakens link target annotation, GO term, or binding-site context

what supports it

target has structure prediction target:7231c56b-062e-48eb-a49e-0dd391e1303b -> fold:9b7022c5-3e4d-4920-ba1b-345f733e8c15 folds_to / B / 0.819

what it supports

measured by AlphaFold confidence context fold:9b7022c5-3e4d-4920-ba1b-345f733e8c15 -> alphafold_metric:9b7022c5-3e4d-4920-ba1b-345f733e8c15 measured_by / B / 0.819
evidence finding attached fold:9b7022c5-3e4d-4920-ba1b-345f733e8c15 -> finding:c948f691-cf7c-4dfd-a2c2-2e3a0becd220 supports / C / 0.6
timeline records state change fold:9b7022c5-3e4d-4920-ba1b-345f733e8c15 -> timeline_event:12 records / C / 0.5

Research-use boundary

This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.